ClinicalTrials.gov record
Recruiting Phase 1 Interventional

A Study of XB628 in Participants With Recurrent Advanced or Metastatic Solid Tumors

ClinicalTrials.gov ID: NCT06952010

Public ClinicalTrials.gov record NCT06952010. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 7:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1 Study of XB628 in Participants With Recurrent Advanced or Metastatic Solid Tumors

Study identification

NCT ID
NCT06952010
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Exelixis
Industry
Enrollment
75 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2025
Primary completion
Apr 30, 2027
Completion
Oct 31, 2027
Last update posted
Dec 25, 2025

2025 – 2027

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
Exelixis Site #5 San Francisco California 94158 Recruiting
Exelixis Site #4 New Haven Connecticut 06520 Recruiting
Exelixis Clinical Site #8 Tampa Florida 33612 Recruiting
Exelixis Clinical Site #10 Boston Massachusetts 02114 Recruiting
Exelixis Site #6 St Louis Missouri 63108 Recruiting
Exelixis Site #7 New York New York 10029 Recruiting
Exelixis Clinical Site #1 Hickory North Carolina 28602 Recruiting
Exelixis Clinical Site #3 Nashville Tennessee 37203 Recruiting
Exelixis Clinical Site #9 Houston Texas 77030 Recruiting
Exelixis Clinical Site #2 San Antonio Texas 78229 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06952010, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 25, 2025 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06952010 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →